Recombinant Cocksfoot mottle virus Polyprotein P2A (ORF2A)

Shipped with Ice Packs
In Stock

Description

Functional Domains and Proteolytic Processing

The P2A polyprotein is processed at conserved cleavage sites to release mature functional proteins:

Cleavage SiteResiduesReleased DomainsRole
E117/A118 (Cis-processing)Glu-SerSerine Protease (Pro)Autocatalytic cleavage
E315/S316 (Trans-processing)Glu-SerVPg + P16RNA binding, replication initiation
E393/S394 (Trans-processing)Glu-SerP8 (putative)Unknown accessory function

The VPg domain is further processed to a 12 kDa mature form, which remains covalently linked to viral RNA .

Recombinant Production and Biophysical Properties

The recombinant P2A is engineered with an N-terminal His-tag for affinity purification and is expressed in E. coli. Key characteristics include:

ParameterDetail
SolubilityRequires reconstitution in deionized water (0.1–1.0 mg/mL)
StabilityLyophilized powder; store at -20°C/-80°C
ReconstitutionUse glycerol (5–50%) to prevent aggregation
RNA-Binding ActivitySequence-nonspecific interaction with ssRNA (optimal at 100–200 mM NaCl)

Research Applications and Functional Insights

Recombinant P2A is critical for studying:

  • Viral RNA Replication: The VPg domain interacts with eIF4G to recruit host ribosomes, bypassing translation initiation barriers .

  • Protease Activity: Autocatalytic cleavage at E117/A118 enables polyprotein processing .

  • Diagnostic Tools: Used in ELISA assays for detecting anti-CfMV antibodies .

Comparative Analysis with Other Sobemoviruses

CfMV P2A shares structural and functional homology with other sobemoviruses, such as rice yellow mottle virus (RYMV) and southern cowpea mosaic virus (SCPMV), but differs in key aspects:

FeatureCfMV P2ARYMV P2ASCPMV P2A
VPg RoleRNA recruitment, translationRNA silencing suppression Cell-to-cell movement
Protease Cleavage SitesE117/A118, E315/S316, E393/S394Similar conserved sites Shared motifs
P16 FunctionMg²⁺-ATPase, RNA binding UnknownUnknown

Challenges and Considerations

  • Aggregation Risk: Repeated freeze-thaw cycles degrade activity .

  • Non-AUG Initiation: ORF2A translation relies on leaky scanning, complicating expression optimization .

  • Post-Translational Modifications: Phosphorylation of VPg may influence RNA binding but remains uncharacterized .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them when placing the order. We will prepare the product according to your request.
Lead Time
Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery times.
Note: All proteins are shipped with standard blue ice packs. If dry ice shipping is required, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure all contents are at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer ingredients, storage temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag type, please inform us, and we will prioritize developing the specified tag.
Synonyms
ORF2A; Polyprotein P2A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
500-568
Protein Length
Full Length of Mature Protein
Species
Cocksfoot mottle virus (isolate Dactylis glomerata/Norway/CfMV-NO/1995) (CfMV)
Target Names
ORF2A
Target Protein Sequence
SKRPPICNWQSLTSKPSTRGPDPAPVSAESPGVVKTSSQKSKRSRTRGKSTSRQVPASPS PKSGSATSK
Uniprot No.

Target Background

Function
The Cocksfoot mottle virus Polyprotein P2A (ORF2A) is responsible for the cleavage of polyprotein P2A and replicase polyprotein P2AB. It is covalently attached to the 5' extremity of the genomic and subgenomic RNAs. It may serve as a primer for the replicase.
Database Links

KEGG: vg:2654592

Subcellular Location
[Polyprotein P2A]: Host membrane; Multi-pass membrane protein.; [N-terminal protein]: Host membrane; Multi-pass membrane protein.

Q&A

What is Cocksfoot mottle virus Polyprotein P2A and what genomic organization does it have?

Cocksfoot mottle virus Polyprotein P2A is a viral protein encoded by the ORF2A gene in the CfMV genome. CfMV has a monopartite, single-stranded, positive-sense RNA genome of 4082 nucleotides . The polyprotein P2A is one of the major translation products and serves as a precursor for multiple functional viral proteins essential for viral replication and infection . The gene is also known by alternative names including CfMVp4 .

In the viral genome, ORF2A is positioned downstream of the coat protein gene and encodes proteins involved in viral replication. The genome organization reflects the typical structure of sobemoviruses, with the P2A polyprotein containing domains for several functional proteins that are released through proteolytic processing .

What are the key structural and functional domains of Recombinant Cocksfoot mottle virus Polyprotein P2A?

The CfMV Polyprotein P2A contains several distinct domains with specific functions in the viral life cycle:

  • N-terminal domain (approximately 60 amino acids): Contains hydrophobic residues proposed to form a transmembrane domain, likely involved in anchoring the polyprotein to cellular membranes during replication

  • Serine proteinase domain: Mediates the proteolytic processing of the polyprotein

  • VPg (Viral Protein genome-linked) domain: A 12 kDa protein that covalently attaches to the viral RNA and likely functions in RNA replication

  • C-terminal region: Contains a strong basic region (amino acids 539-552) that may be involved in RNA binding

The functional arrangement of these domains is essential for the proper processing and functioning of the viral proteins during infection.

What expression systems are most effective for producing Recombinant Cocksfoot mottle virus Polyprotein P2A?

Several expression systems have been successfully employed for the production of Recombinant Cocksfoot mottle virus Polyprotein P2A:

Expression SystemAdvantagesConsiderations
E. coliHigh yield, cost-effective, rapid productionMay have issues with protein folding and post-translational modifications
YeastBetter protein folding, some post-translational modificationsLonger production time compared to E. coli
BaculovirusSuperior for complex proteins, eukaryotic post-translational modificationsMore expensive, technically demanding
Mammalian CellBest for authentic post-translational modificationsHighest cost, lower yield, longer production time
Cell-Free ExpressionRapid, allows production of toxic proteinsLimited scale, relatively expensive

According to available data, all these expression systems can produce the recombinant protein with ≥85% purity as determined by SDS-PAGE . The choice of expression system should be based on the specific research requirements, particularly whether post-translational modifications are critical for the intended studies.

What purification and quality control methods are recommended for Recombinant Cocksfoot mottle virus Polyprotein P2A?

Standard purification procedures for Recombinant Cocksfoot mottle virus Polyprotein P2A typically involve:

  • Initial capture: Affinity chromatography (if tagged) or ion exchange chromatography

  • Intermediate purification: Size exclusion chromatography

  • Polishing: Reversed-phase HPLC or hydrophobic interaction chromatography

Quality control methods should include:

  • SDS-PAGE analysis: To verify purity (≥85% purity is considered acceptable for most research applications)

  • Western blot analysis: Using specific antibodies against P2A to confirm identity

  • Mass spectrometry: To verify the molecular mass and sequence integrity

  • Functional assays: To confirm biological activity if applicable

For researchers working with the VPg domain specifically, it's important to note that the fully processed 12 kDa VPg detected in viral RNA-derived samples appears to be a minor product in infected plants , which may influence experimental design considerations.

How does the VPg domain of CfMV Polyprotein P2A compare structurally and functionally to VPg in other related viruses?

The VPg domain of CfMV Polyprotein P2A shows significant differences from VPg domains in other related viruses:

  • N-terminal sequence comparison:

    • CfMV VPg: VTVE/NSELYPDQSS

    • SBMV VPg: RSQE/TLPPELSVIE

These sequence differences suggest divergent evolutionary paths and potentially different functional mechanisms.

  • Domain organization:
    In CfMV, the VPg domain is located between the serine proteinase and replicase motifs , a positioning that appears conserved among sobemoviruses but with variability in the exact boundaries and processing.

  • Functional implications:
    The 12 kDa VPg protein detected in viral RNA-derived samples is only a minor product in infected plants, where a 24 kDa protein recognized by VPg antiserum predominates . This suggests that the fully processed form may not be the primary functional unit in vivo, unlike some other viral systems where the processed VPg is the predominant form.

The differences in sequence, processing, and in vivo forms suggest that despite similar general functions in viral replication, the molecular mechanisms of CfMV VPg may differ from those of other sobemoviruses.

What experimental approaches are most effective for studying P2A-host protein interactions?

Several complementary approaches are recommended for investigating P2A-host protein interactions:

  • Yeast two-hybrid screening:

    • Allows systematic identification of host proteins interacting with P2A or its processed products

    • Should be performed with both full-length P2A and individual domains

    • Requires validation by secondary methods

  • Co-immunoprecipitation coupled with mass spectrometry:

    • More physiologically relevant than Y2H

    • Can identify interactions in plant cells during infection

    • Protocol should include crosslinking to capture transient interactions

  • Bimolecular Fluorescence Complementation (BiFC):

    • Enables visualization of protein interactions in living cells

    • Particularly useful for determining subcellular localization of interactions

    • Can validate candidates from Y2H or co-IP studies

  • Surface Plasmon Resonance (SPR) or Microscale Thermophoresis (MST):

    • Provides quantitative binding kinetics data

    • Requires purified proteins

    • Useful for characterizing specific interactions identified by other methods

  • Proximity-based labeling (BioID or APEX):

    • Identifies proteins in close proximity to P2A in living cells

    • Less biased than traditional pull-down methods

    • Can capture transient or weak interactions

When designing these experiments, researchers should consider the membrane association of P2A through its hydrophobic N-terminal domain , which may influence the experimental conditions required for detecting authentic interactions.

How can site-directed mutagenesis be optimally employed to investigate functional domains in CfMV Polyprotein P2A?

Site-directed mutagenesis represents a powerful approach for dissecting the functional domains of CfMV Polyprotein P2A. Strategic approaches include:

  • Cleavage site mutations:

    • Target the E/N cleavage sites identified between glutamic acid and asparagine residues

    • Create non-cleavable mutants by replacing either E or N with alanine

    • Analyze effects on polyprotein processing and viral infectivity

  • Catalytic site mutations in the serine proteinase domain:

    • Identify and mutate the catalytic triad (likely Ser, His, Asp)

    • Assess effects on both cis and trans proteolytic activities

    • Determine whether external proteases can compensate for mutated viral proteinase

  • VPg functional mutations:

    • Target conserved residues within the VPg domain

    • Focus on tyrosine residues potentially involved in RNA linkage

    • Investigate basic residues that might participate in RNA binding

  • Membrane association mutations:

    • Modify the hydrophobic N-terminal region (first 60 amino acids)

    • Create deletion mutants or replace hydrophobic residues

    • Analyze impacts on subcellular localization and replication complex formation

  • RNA-binding region mutations:

    • Target the C-terminal basic region (amino acids 539-552)

    • Replace basic residues with alanines

    • Assess effects on RNA binding and replication

For all mutagenesis studies, it is essential to establish an efficient reverse genetics system for CfMV to evaluate the phenotypic consequences of mutations in the context of viral infection.

What approaches are most effective for investigating the membrane association and subcellular localization of P2A?

The hydrophobic N-terminal region of P2A has been proposed to form a transmembrane domain , suggesting membrane association is critical for its function. To investigate this aspect:

  • Fluorescence microscopy techniques:

    • Express GFP-tagged P2A or domains in plant cells

    • Use confocal microscopy with membrane-specific dyes

    • Apply FRAP (Fluorescence Recovery After Photobleaching) to assess membrane dynamics

  • Biochemical fractionation:

    • Separate cellular components (cytosol, membranes, nuclei)

    • Analyze distribution of P2A across fractions by Western blotting

    • Use differential detergent treatments to assess membrane integration strength

  • Electron microscopy:

    • Employ immunogold labeling to visualize P2A at high resolution

    • Apply correlative light and electron microscopy (CLEM) for context

    • Focus on virus-induced membrane rearrangements

  • Membrane flotation assays:

    • Place cell lysates in sucrose gradients

    • Centrifuge and collect fractions

    • Analyze P2A distribution relative to known membrane markers

  • Domain swapping experiments:

    • Replace the N-terminal hydrophobic domain with equivalent regions from other viruses

    • Create chimeric constructs with known membrane-targeting signals

    • Assess effects on localization and function

These approaches should be conducted in both infected plant cells and heterologous expression systems to distinguish virus-specific effects from intrinsic protein properties.

What are the key challenges in purifying functionally active Recombinant Cocksfoot mottle virus Polyprotein P2A?

Purifying functionally active P2A presents several challenges:

  • Proteolytic processing:

    • The polyprotein undergoes self-processing through its proteinase domain

    • May yield heterogeneous products during expression and purification

    • Consider using protease inhibitors or inactivating the catalytic site for full-length protein studies

  • Membrane association:

    • The N-terminal hydrophobic domain makes the protein difficult to solubilize

    • May require detergents or specific buffer conditions

    • Consider using detergent screening to identify optimal solubilization conditions

  • Protein stability:

    • Viral polyproteins often have disordered regions

    • May be prone to aggregation or degradation

    • Test various buffer conditions and stabilizing agents (glycerol, arginine)

  • Expression system selection:

    • E. coli systems may not provide proper folding

    • Higher eukaryotic systems may process the polyprotein differently

    • Cell-free expression may offer advantages for controlling processing

  • Functional assessment:

    • Developing assays to confirm biological activity is challenging

    • Consider RNA binding, protease activity, or protein-protein interaction assays

    • May need to validate with in vitro translation systems

When purifying specific domains like VPg, it's important to note that the fully processed 12 kDa form appears to be a minor product in infected plants compared to a 24 kDa version recognized by VPg antiserum , suggesting that physiologically relevant forms may differ from theoretical predictions.

How can researchers effectively design experiments to study the role of P2A in viral RNA replication?

Studying P2A's role in viral RNA replication requires multifaceted approaches:

  • In vitro replication assays:

    • Develop cell-free systems containing purified components

    • Include P2A or processed products, viral RNA templates, and cellular extracts

    • Measure RNA synthesis using radiolabeled nucleotides or fluorescent tags

  • Reverse genetics approaches:

    • Generate viral mutants with specific alterations in P2A domains

    • Transfect protoplasts or plants and assess viral replication

    • Use quantitative RT-PCR to measure viral RNA accumulation

  • Replicon systems:

    • Develop mini-genome replicons expressing reporter proteins

    • Co-express wild-type or mutant P2A proteins

    • Measure reporter activity as a proxy for replication efficiency

  • Time-course analyses:

    • Sample infected tissues at different time points

    • Track P2A processing and localization relative to viral RNA accumulation

    • Correlate processing patterns with replication phases

  • Identification of replication complexes:

    • Use antibodies against P2A to immunoprecipitate replication complexes

    • Extract and analyze co-purifying RNA and proteins

    • Sequence viral RNAs to identify replication intermediates

These approaches should be integrated with structural biology techniques whenever possible to correlate function with structure.

How does CfMV Polyprotein P2A compare with similar proteins in other sobemoviruses?

Comparative analysis reveals both conserved and divergent features between CfMV P2A and related proteins in other sobemoviruses:

Key differences:

  • The N-terminal cleavage site of CfMV VPg occurs between glutamic acid (E) and asparagine (N), which differs from the predicted (Q,E)/(G,S,A) sites in luteoviruses and sobemoviruses .

  • The amino acid sequence surrounding the cleavage site of the N terminus of CfMV VPg doesn't show similarity to those in SBMV or Rice yellow mottle virus (RYMV) .

  • The processing pattern observed in CfMV, where a 24 kDa protein containing VPg is predominant in infected plants rather than the fully processed 12 kDa form , may represent a virus-specific characteristic.

These differences suggest that while the general genomic organization and functional domains are conserved among sobemoviruses, the specific processing mechanisms and protein interactions may have evolved distinct characteristics in CfMV.

What insights from poleroviruses might apply to understanding CfMV P2A function?

Despite taxonomic differences, research on poleroviruses provides valuable insights for CfMV P2A studies:

  • Membrane association mechanism:
    In Potato leafroll virus (PLRV), a polerovirus, it has been proposed that the hydrophobic N-terminal region targets the polyprotein to cellular membranes while the basic nucleic acid-binding domain at its C terminus interacts with viral RNA . This model may be applicable to CfMV polyprotein processing due to similarities in polyprotein sequence and arrangement .

  • VPg processing dynamics:
    The observation that fully processed VPg is a minor component in CfMV-infected plants aligns with findings in some poleroviruses where VPg exists in various processed forms with different functions.

  • Replication complex formation:
    The membrane-bound complex of viral polyprotein and RNA could serve as a proteolytic processing site for VPg maturation in both virus groups .

These parallels suggest that sobemoviruses and poleroviruses may share similar proteolytic processing strategies despite differences in genome organization, providing additional experimental approaches for CfMV research based on successful polerovirus studies.

What are the major unanswered questions regarding CfMV Polyprotein P2A?

Several critical knowledge gaps remain in our understanding of CfMV Polyprotein P2A:

  • Complete processing map:
    While some cleavage sites have been identified , the full complement of processing events and their temporal regulation during infection remains unclear.

  • Structural information:
    High-resolution structural data for P2A or its domains is lacking, limiting our understanding of how structure relates to function.

  • Host factor interactions:
    The complete set of host proteins that interact with P2A or its processed products remains to be identified.

  • Membrane rearrangements:
    How P2A contributes to virus-induced membrane rearrangements for replication complex formation is poorly understood.

  • Role in host range determination:
    Whether variations in P2A contribute to host specificity or adaptation remains an open question.

What emerging technologies could advance research on CfMV Polyprotein P2A?

Several cutting-edge approaches could significantly advance CfMV P2A research:

  • Cryo-electron microscopy:

    • Could provide structural insights into P2A and its complexes

    • Particularly valuable for membrane-associated forms

  • Proximity labeling proteomics:

    • BioID or APEX2 fusions to identify proteins in close proximity to P2A

    • Can capture transient interactions in the cellular context

  • Single-molecule techniques:

    • FRET or optical tweezers to study protein dynamics and RNA interactions

    • Could reveal mechanistic details of replication

  • CRISPR-based approaches:

    • Genome-wide screens to identify host factors required for P2A function

    • Base editing to create subtle mutations in viral sequences

  • Artificial intelligence applications:

    • Structure prediction through AlphaFold or similar tools

    • Mining of existing datasets for patterns in viral polyprotein evolution

  • High-throughput mutagenesis:

    • Deep mutational scanning to comprehensively assess functional impacts

    • Could identify previously overlooked functional residues

These technologies could help bridge current knowledge gaps and provide new insights into the fundamental biology of CfMV and related viruses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.